Compare NN & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NN | OPCH |
|---|---|---|
| Founded | 2007 | N/A |
| Country | United States | United States |
| Employees | 103 | N/A |
| Industry | Industrial Machinery/Components | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 3.5B |
| IPO Year | N/A | 1996 |
| Metric | NN | OPCH |
|---|---|---|
| Price | $12.68 | $21.81 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | $25.00 | ★ $36.57 |
| AVG Volume (30 Days) | ★ 2.2M | 2.0M |
| Earning Date | 05-14-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.25 |
| EPS | N/A | ★ 0.29 |
| Revenue | N/A | ★ $4,998,202,000.00 |
| Revenue This Year | N/A | $7.21 |
| Revenue Next Year | N/A | $8.55 |
| P/E Ratio | ★ N/A | $74.69 |
| Revenue Growth | N/A | ★ 16.17 |
| 52 Week Low | $10.87 | $18.01 |
| 52 Week High | $24.42 | $36.80 |
| Indicator | NN | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 27.25 | 52.42 |
| Support Level | $11.62 | $20.82 |
| Resistance Level | $13.58 | $22.43 |
| Average True Range (ATR) | 1.07 | 0.59 |
| MACD | -0.17 | -0.00 |
| Stochastic Oscillator | 6.03 | 61.62 |
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system delivers resilient, next-generation, complementary positioning, navigation, and timing (PNT) solutions designed to overcome the limitations and vulnerabilities of existing space-based Global Navigation Satellite Systems (GNSS), including the Global Positioning System (GPS). The products of the company include NextNav Pinnacle: Accurate vertical location, NextNav 3D: 3D location visualization, NextNav TerraPoiNT: Resilient PNT for 3D and indoor geolocation, Next Generation Solution: Terrestrial 3D PNT powered by spectrum.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.